LIR Life Sciences Corp (SKNY) Stock Price & News

All values in CAD	2025-ж. окт.	2026-ж. янв.	2026-ж. апр.	2026-ж. июл.
Revenue	-	-	-	-
Cost of goods sold	-	-	6,67 миң	5,00 миң
Cost of revenue	-	-	6,67 миң	5,00 миң
Research and development expenses	-	10,00 миң	52,10 миң	255,17 миң
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	61,85 миң	1,13 млн	317,32 миң	323,37 миң
Operating expense	67,88 миң	1,87 млн	1,23 млн	981,44 миң
Total operating expenses	67,88 миң	1,87 млн	1,24 млн	986,44 миң
Operating income	-67,88 миң	-1,87 млн	-1,24 млн	-986,44 миң
Other non operating income	-6,52 миң	-343,44 миң	-57,71 миң	-3,70 миң
EBT including unusual items	-64,24 миң	-2,16 млн	-1,40 млн	-989,04 миң
EBT excluding unusual items	-196,00 миң	-2,21 млн	-1,30 млн	-989,04 миң
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-64,24 миң	-2,16 млн	-1,40 млн	-989,04 миң
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	142,00	-	-	20,00
Interest expense	-	-	-	-
Net interest expenses	10,69 миң	-	-	20,00
Depreciation and amortization charges	-	-	1,28 миң	-
EBITDA	-64,40 миң	-1,87 млн	-1,24 млн	-985,20 миң
Gain or loss from assets sale	-	-	-	-

Finance